randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als Frontiers | Metabolic Dysfunctions in
Frontiers Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments Clinical Evidence of Acetyl L Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial PMC Oral Acetyl L Carnitine treatment in hepatic encephalopathy: view of evidence based medicine Annals of Hepatology Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



